Search results
Results From The WOW.Com Content Network
The pharmaceutical industry in Pakistan was estimated to be worth Rs. 748 billion (US$2.6 billion) in 2023, representing about 1% of the country's GDP. [1] The industry is largely import-dependent, with more than 90% of raw material being imported and only 12% of active pharmaceutical ingredients locally produced. [1]
Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris, France. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers ...
This listing is limited to those independent companies and subsidiaries notable enough to have their own articles in Wikipedia. Both going concerns and defunct firms are included, as well as firms that were part of the pharmaceutical industry at some time in their existence, provided they were engaged in the production of human (as opposed to veterinary) therapeutics.
Ali is the Chairman of Sanofi-Aventis Pakistan Limited, Siemens Pakistan Engineering Company Limited, and Coca-Cola Beverages Pakistan Limited. He believes in the joint venture philosophy and most of his businesses are joint ventures with major multinationals. [2]
2004: merger of Aventis with and into Sanofi. The new Sanofi-Aventis Group becomes the world's 3rd largest pharmaceutical company, behind Pfizer and GlaxoSmithKline. Aventis Pasteur, the vaccine division of the Sanofi-Aventis Group, changes its name to Sanofi Pasteur. 2008: Sanofi Pasteur acquires Acambis plc, a biotech company.
Sanofi plans to advance blood cancer drugs known as anti-CD38, which include Sarclisa, despite GenMab and Johnson & Johnson's strong foothold with Darzalex in the same class.
Later on, a further merger with Sanofi-Synthélabo in 2004 changed the Dagenham site owner to Sanofi-Aventis. In 2009 Sanofi-Aventis announced their intention to close the Dagenham plant by 2013. [6] Sanofi's plans to turn the former site into a state-of-the-art science park were put in doubt by a lack of funding from London mayor Boris Johnson ...
Amgen – Amgen Ltd; APS – TEVA UK Ltd; Assertio – Assertio Therapeutics, Inc; AstraZeneca – AstraZeneca UK Limited; Aventis Pharma – Sanofi-Aventis Ltd; Bausch & Lomb – Bausch & Lomb UK Ltd; Baxter – Baxter International; Baxter BioScience – Baxter International; Bayer – Bayer plc (Pharmaceutical Division) Becton Dickinson ...